Background: Although there are many studies of the predictors of death in hepatocellular
carcinoma (HCC), most combine patients with and without cirrhosis and many combine …

Alpha‐fetoprotein is a tumor marker that has been used for surveillance and diagnosis of
hepatocellular carcinoma (HCC) in patients with cirrhosis. The prognostic capability of this …

Background While the majority of studies report that a raised serum α-fetoprotein (AFP) level
before operation is associated with a high risk of recurrence and death in patients who …

AIM: To clarify the utility of using des-γ-carboxy prothrombin (DCP) and α-fetoprotein (AFP)
levels to predict the prognosis of hepatocellular carcinoma (HCC) in patients with hepatitis B …

Abstract Background and Aims: As the merits of screening at‐risk populations for
hepatocellular carcinoma (HCC) remain unclear, we compared the clinico‐pathologic …

Abstract Background Hepatitis B (HBV)-associated hepatocellular carcinoma (HCC) is often
associated with alpha-fetoprotein (AFP) production. Although serum AFP has been …

Exosomes are protein-containing vesicles that are secreted into the blood to mediate
important biological and pathological processes. The present study enrolled 86 patients with …

Introduction and objectives Liver resection is the only curative therapeutic option for large
hepatocellular carcinoma (> 5 cm), but survival is worse than in smaller tumours, mostly due …

AIM: To comprehend the risk factors of recurrence of hepatocellular carcinoma (HCC) and its
relationship with the infection patterns of hepatitis B virus (HBV). METHODS: All materials of …

Background Alpha-fetoprotein (AFP) is the most established tumor marker of hepatocellular
carcinoma (HCC), but one of its limitations is non-specificity. Many studies have …